<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-biomedicines-08-00060">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shapira</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Shapira</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Kazanov</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Hevroni</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Kraus</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Arber</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>Selective eradication of cancer cells by delivery of adenovirus-based toxins</article-title>
  <source>Oncotarget</source>
  <year>2017</year>
  <volume>8</volume>
  <fpage>38581</fpage>
  <pub-id pub-id-type="doi">10.18632/oncotarget.16934</pub-id>
  <pub-id pub-id-type="pmid">28445136</pub-id>
 </element-citation>
</ref>
